Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Gridelli

Showing results (71-80 of 126) with videos related to

Pageof 13
Sort By:
European Journal of Cancer (Oxford, England : 1990)|July 15, 2009
Targeted therapies in the treatment of advanced/metastatic NSCLCA G Pallis, L Serfass, R Dziadziusko, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 30, 2006
Chemotherapy of advanced NSCLC in special patient populationC Gridelli, P Maione, A Rossi, et al.
Tumori|December 31, 1991
Salvage chemotherapy with CCNU and methotrexate for small cell lung cancer resistant to CAV/PE alternating chemotherapyC Gridelli, A Contegiacomo, R Lauria, et al.
Lung Cancer (Amsterdam, Netherlands)|July 1, 1994
Carboplatin plus epirubicin plus VP-16, concurrent 'split course' radiotherapy and adjuvant surgery for limited small cell lung cancer. Gruppo Oncologico Centro-Sud-Isole (GOCSI)C Gridelli, M D'Aprile, C Curcio, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
Phase II study of mitomycin C, etoposide and vindesine in metastatic stage IV non-small-cell lung cancerC Gridelli, R Pepe, S Palmeri, et al.
European Journal of Cancer (Oxford, England : 1990)|December 1, 1995
Phase II study of intensive CEV (carboplatin, epirubicin and VP-16) plus G-CSF (granulocyte-colony stimulating factor) in extensive small cell lung cancerC Gridelli, F Perrone, M D'Aprile, et al.
American Journal of Clinical Oncology|December 1, 1996
Phase I study of chemotherapy with carboplatin, epirubicin, and escalating dose of VP-16 with G-CSF support in extensive small cell lung cancerC Gridelli, M D'Aprile, S Palmeri, et al.
Tumori|December 31, 1992
Neoadjuvant chemotherapy with cisplatin, epirubicin and VP-16 for stage IIIA-IIIB non-small-cell lung cancer: a pilot studyC Gridelli, S Iacobelli, T Martino, et al.
American Journal of Clinical Oncology|April 1, 1994
Carboplatin, epirubicin, and VP-16 chemotherapy in the treatment of small cell lung cancerC Gridelli, G P Ianniello, A Maiorino, et al.
European Journal of Cancer (Oxford, England : 1990)|December 16, 1998
A phase II study of gemcitabine in patients with transitional cell carcinoma of the urinary tract previously treated with platinum. Italian Co-operative Group on Bladder CancerV Lorusso, C F Pollera, M Antimi, et al.
Pageof 13

Showing results (71-80 of 126) with videos related to

Sort By:
Pageof 13
European Journal of Cancer (Oxford, England : 1990)|July 15, 2009
Targeted therapies in the treatment of advanced/metastatic NSCLCA G Pallis, L Serfass, R Dziadziusko, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 30, 2006
Chemotherapy of advanced NSCLC in special patient populationC Gridelli, P Maione, A Rossi, et al.
Tumori|December 31, 1991
Salvage chemotherapy with CCNU and methotrexate for small cell lung cancer resistant to CAV/PE alternating chemotherapyC Gridelli, A Contegiacomo, R Lauria, et al.
Lung Cancer (Amsterdam, Netherlands)|July 1, 1994
Carboplatin plus epirubicin plus VP-16, concurrent 'split course' radiotherapy and adjuvant surgery for limited small cell lung cancer. Gruppo Oncologico Centro-Sud-Isole (GOCSI)C Gridelli, M D'Aprile, C Curcio, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
Phase II study of mitomycin C, etoposide and vindesine in metastatic stage IV non-small-cell lung cancerC Gridelli, R Pepe, S Palmeri, et al.
European Journal of Cancer (Oxford, England : 1990)|December 1, 1995
Phase II study of intensive CEV (carboplatin, epirubicin and VP-16) plus G-CSF (granulocyte-colony stimulating factor) in extensive small cell lung cancerC Gridelli, F Perrone, M D'Aprile, et al.
American Journal of Clinical Oncology|December 1, 1996
Phase I study of chemotherapy with carboplatin, epirubicin, and escalating dose of VP-16 with G-CSF support in extensive small cell lung cancerC Gridelli, M D'Aprile, S Palmeri, et al.
Tumori|December 31, 1992
Neoadjuvant chemotherapy with cisplatin, epirubicin and VP-16 for stage IIIA-IIIB non-small-cell lung cancer: a pilot studyC Gridelli, S Iacobelli, T Martino, et al.
American Journal of Clinical Oncology|April 1, 1994
Carboplatin, epirubicin, and VP-16 chemotherapy in the treatment of small cell lung cancerC Gridelli, G P Ianniello, A Maiorino, et al.
European Journal of Cancer (Oxford, England : 1990)|December 16, 1998
A phase II study of gemcitabine in patients with transitional cell carcinoma of the urinary tract previously treated with platinum. Italian Co-operative Group on Bladder CancerV Lorusso, C F Pollera, M Antimi, et al.
Pageof 13